The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Plenty of folks have been using GLP-1s — generic versions of popular weight loss drugs such as Ozempic and Zepbound — to jump-start their health journeys lately. But those folks could be in for bad ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to ...

Some people have experienced insomnia (difficulty sleeping) after ... itself since Zepbound is more likely to cause tiredness. Zepbound is a brand-name drug prescribed for weight loss and long ...

Because of the difference in dosage, Ozempic is FDA-approved only to treat type 2 diabetes, while Wegovy is FDA-approved for weight loss. Likewise, Mounjaro and Zepbound are also identical ...

Even a little weight loss can work wonders for your health. A study found that people at high risk for developing type 2 diabetes who lost 5-7% of their weight had a 58% lower risk of developing it.

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S ... against compounders before the court ruled.